Who
Jennifer B. Damico
SVP & Controller
Company insider
Files Form 4 as: SVP & Controller, Pfizer.
In numbers
- Trades disclosed
- 212
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 13 Mar 2020
- Last trade
- 5 Aug 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 6 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Sold | $83K3,278 at $25.40 | filing |
| 5 Aug 2026filed 6 Aug 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Sold | $83K3,278 at $25.40 | filing |
| 9 Jun 2026filed 10 Jun 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Sold | $51K2,000 at $25.70 | filing |
| 9 Jun 2026filed 10 Jun 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Sold | $51K2,000 at $25.70 | filing |
| 4 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $22K826 at $26.62 | filing |
| 4 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $22K826 at $26.62 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code A | —16,311 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code A | —5,408 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —22,638 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —22,638 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code A | —16,311 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code A | —5,408 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $18K655 at $27.65 | filing |
| 27 Feb 2026filed 3 Mar 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $18K655 at $27.65 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code M | $594K17,558 at $33.82 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $9,779361 at $27.09 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code F | $449K16,687 at $26.92 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,558 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE Pfizeroption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,558 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | PFE PfizerPharmaceuticals | SEC FORM 4 Code M | $594K17,558 at $33.82 | filing |
News
Pfizer layoffs announced at Rocky Mount, Sanford facilities in NCPFE · abc11.com · 21 Oct 2026Critical Analysis: Nexentis Technologies (NASDAQ:NXTS) versus Pfizer (NYSE:PFE)PFE · dailypolitical.com · 19 Oct 2026Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?PFE · fool.com · 19 Oct 2026
0 headlines in the last 90 days name Jennifer B. Damico; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.